MODIFICATION
68 -- Anthrax Vaccine Adsorbed for the Strategic National Stockpile (SNS)
- Notice Date
- 5/15/2007
- Notice Type
- Modification
- NAICS
- 325414
— Biological Product (except Diagnostic) Manufacturing
- Contracting Office
- Department of Health and Human Services, Office of the Secretary, Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority 330 Independence Avenue, SW, Rm G640, Washington, DC, 20201, UNITED STATES
- ZIP Code
- 00000
- Solicitation Number
- RFP-DHHS-OPHEMC-VB-07-02
- Response Due
- 5/1/2007
- Archive Date
- 5/16/2007
- Point of Contact
- Brian Goodger, Contracting Officer, Phone 202-205-5664, Fax 202-205-6092, - Brian Goodger, Contracting Officer, Phone 202-205-5664, Fax 202-205-6092,
- E-Mail Address
-
Brian.Goodger@hhs.gov, Brian.Goodger@hhs.gov
- Description
- This is a Notice of Intent to negotiate with only one source. The U.S. Government intends to acquire for the SNS 10.4 million doses of a licensed anthrax vaccine, with options for up to an additional 8.35 million doses. Currently there is only one manufacture who can supply FDA licensed anthrax vaccine: Emergent BioDefense Operations of Lansing, Michigan. The Government intends to enter sole source negotiations with Emergent BioDefense using the authority of 41 USC 253(c)(1). This notice of intent is not a request for proposal (RFP). The Government expects to make one award on or about 7/24/07. The determination by the Government not to compete the proposed contract under full and open competition procedures based upon responses to this notice is solely within the discretion of the Government. Interested parties may identify their interest and capabilities in response to this notice of intent by submitting a capability statement to Brian K. Goodger, Contracting Officer, at the mailing address below by 5/1/07. Comments to this announcement, referencing synopsis RFP-DHHS-OPHEMC-V&B-07-02 may be submitted to Brian K. Goodger at 202-260-0333 or in writing to Brian.Goodger@hhs.gov This proposed acquisition is subject to the availability of funds.
- Place of Performance
- Address: Emergent BioDefense Operations Lansing, Inc., 3500 N. Martin Luther King, Jr. Blvd., Lansing, Michigan
- Zip Code: 48906
- Country: UNITED STATES
- Zip Code: 48906
- Record
- SN01294747-W 20070517/070515220415 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |